Alpa Laboratories Ltd is engaged in manufacturing of pharmaceutical finished dosage forms since 1967.
Financial Results:
Alpa Laboratories Ltd reported Revenues for Q1FY24 of ₹25.43 Crores up from ₹22.42 Crore year on year, a rise of 13.43%.
Total Expenses for Q1FY24 of ₹26.88 Crores up from ₹21.37 Crores year on year, a rise of 25.78%.
Consolidated Net Profit of ₹3.03 Crores up 13.91% from ₹2.66 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.44, up 14.29% from ₹1.26 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.